Vespa crabro chromosome 5, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342404.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC124424065, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124424065, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124424065, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X8
COORDINATES: polyA evidence [ECO:0006239]
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X11
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X7
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X10
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X6
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X9
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X4
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X3
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X2
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X1
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X5
5-methylcytosine rRNA methyltransferase NSUN4 isoform X3
5-methylcytosine rRNA methyltransferase nsun-4 isoform X4
5-methylcytosine rRNA methyltransferase nsun-4 isoform X1
5-methylcytosine rRNA methyltransferase NSUN4 isoform X2
5-methylcytosine rRNA methyltransferase NSUN4 isoform X5
uncharacterized LOC124424291, transcript variant X2
uncharacterized LOC124424291, transcript variant X3
uncharacterized LOC124424291, transcript variant X1
protein tramtrack, beta isoform, transcript variant X1
protein tramtrack, beta isoform, transcript variant X2
protein tramtrack, beta isoform, transcript variant X4
protein tramtrack, beta isoform, transcript variant X3
protein tramtrack, alpha isoform isoform X1
protein tramtrack, beta isoform isoform X2
uncharacterized LOC124424289, transcript variant X3
uncharacterized LOC124424289, transcript variant X2
uncharacterized LOC124424289, transcript variant X1
aspartate aminotransferase, mitochondrial
uncharacterized LOC124424117, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC124424117, transcript variant X1
uncharacterized protein LOC124424117 isoform X1
uncharacterized protein LOC124424117 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124424297, transcript variant X1
uncharacterized LOC124424297, transcript variant X2
uncharacterized protein LOC124424297 isoform X1
uncharacterized protein LOC124424297 isoform X2
probable sodium/potassium/calcium exchanger CG1090
COMM domain-containing protein 4, transcript variant X1
COMM domain-containing protein 4, transcript variant X2
uncharacterized LOC124424327, transcript variant X2
uncharacterized LOC124424327, transcript variant X1
COMM domain-containing protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124424238, transcript variant X1
uncharacterized LOC124424238, transcript variant X2
nuclear envelope integral membrane protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear envelope integral membrane protein 1 isoform X1
nuclear envelope integral membrane protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nuclear envelope integral membrane protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 2, transcript variant X1
cytoplasmic polyadenylation element-binding protein 2, transcript variant X2
cytoplasmic polyadenylation element-binding protein 2 isoform X1
cytoplasmic polyadenylation element-binding protein 2 isoform X2
LIM domain-binding protein 2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X12
LIM domain-binding protein 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X6
LIM domain-binding protein 2, transcript variant X4
LIM domain-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X1
LIM domain-binding protein 2, transcript variant X10
LIM domain-binding protein 2, transcript variant X8
LIM domain-binding protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
AT-rich interactive domain-containing protein 5B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
AT-rich interactive domain-containing protein 5B-like, transcript variant X1
AT-rich interactive domain-containing protein 5B-like isoform X1
AT-rich interactive domain-containing protein 5B-like isoform X2
AT-rich interactive domain-containing protein 5B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
AT-rich interactive domain-containing protein 5B-like isoform X3
uncharacterized LOC124424315, transcript variant X1
uncharacterized LOC124424315, transcript variant X3
uncharacterized LOC124424315, transcript variant X2
uncharacterized LOC124424315, transcript variant X5
uncharacterized LOC124424315, transcript variant X4
uncharacterized protein LOC124424315 isoform X1
uncharacterized protein LOC124424315 isoform X2
transmembrane protein 230, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 230, transcript variant X6
transmembrane protein 230, transcript variant X5
transmembrane protein 230, transcript variant X7
transmembrane protein 230, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane protein 230, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 230, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124424023, transcript variant X1
uncharacterized LOC124424023, transcript variant X2
replication factor C subunit 5, transcript variant X5
replication factor C subunit 5, transcript variant X3
replication factor C subunit 5, transcript variant X2
replication factor C subunit 5, transcript variant X1
replication factor C subunit 5, transcript variant X4
replication factor C subunit 5 isoform X2
replication factor C subunit 5 isoform X1
replication factor C subunit 5 isoform X3
26S proteasome non-ATPase regulatory subunit 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 26S proteasome non-ATPase regulatory subunit 6-like
uncharacterized LOC124424210, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124424210, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124424210, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124424210, transcript variant X3
uncharacterized LOC124424210, transcript variant X2
uncharacterized protein LOC124424210 isoform X4
uncharacterized protein LOC124424210 isoform X3
uncharacterized protein LOC124424210 isoform X2
uncharacterized protein LOC124424210 isoform X1
mitochondrial import inner membrane translocase subunit TIM14
growth hormone-regulated TBC protein 1-A, transcript variant X1
growth hormone-regulated TBC protein 1-A, transcript variant X2
growth hormone-regulated TBC protein 1-A isoform X2
growth hormone-regulated TBC protein 1-A isoform X1
eukaryotic translation initiation factor 2A, transcript variant X1
eukaryotic translation initiation factor 2A, transcript variant X2
eukaryotic translation initiation factor 2A isoform X1
eukaryotic translation initiation factor 2A isoform X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X4
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X5
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X6
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X3
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X3
peroxisomal (S)-2-hydroxy-acid oxidase GLO1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
peroxisomal (S)-2-hydroxy-acid oxidase GLO1, transcript variant X4
peroxisomal (S)-2-hydroxy-acid oxidase GLO1, transcript variant X2
peroxisomal (S)-2-hydroxy-acid oxidase GLO1, transcript variant X1
peroxisomal (S)-2-hydroxy-acid oxidase GLO1
N-acetylgalactosaminyltransferase 6-like
TLD domain-containing protein 2, transcript variant X17
TLD domain-containing protein 2, transcript variant X13
TLD domain-containing protein 2, transcript variant X11
TLD domain-containing protein 2, transcript variant X12
TLD domain-containing protein 2, transcript variant X10
TLD domain-containing protein 2, transcript variant X3
TLD domain-containing protein 2, transcript variant X1
TLD domain-containing protein 2, transcript variant X2
TLD domain-containing protein 2, transcript variant X15
TLD domain-containing protein 2, transcript variant X5
TLD domain-containing protein 2, transcript variant X4
TLD domain-containing protein 2, transcript variant X7
TLD domain-containing protein 2, transcript variant X6
TLD domain-containing protein 2, transcript variant X8
TLD domain-containing protein 2, transcript variant X9
TLD domain-containing protein 2, transcript variant X16
TLD domain-containing protein 2, transcript variant X14
TLD domain-containing protein 2, transcript variant X18
TLD domain-containing protein 2, transcript variant X20
TLD domain-containing protein 2, transcript variant X19
TLD domain-containing protein 2, transcript variant X22
TLD domain-containing protein 2, transcript variant X21
oxidation resistance protein 1 isoform X14
oxidation resistance protein 1 isoform X10
nuclear receptor coactivator 7 isoform X9
nuclear receptor coactivator 7 isoform X8
nuclear receptor coactivator 7 isoform X3
oxidation resistance protein 1 isoform X7
oxidation resistance protein 1 isoform X6
nuclear receptor coactivator 7 isoform X5
nuclear receptor coactivator 7 isoform X2
nuclear receptor coactivator 7 isoform X4
nuclear receptor coactivator 7 isoform X1
oxidation resistance protein 1 isoform X12
oxidation resistance protein 1 isoform X11
oxidation resistance protein 1 isoform X13
TLD domain-containing protein 2 isoform X15
TLD domain-containing protein 2 isoform X16
TLD domain-containing protein 2 isoform X18
TLD domain-containing protein 2 isoform X17
cilia- and flagella-associated protein 36, transcript variant X2
cilia- and flagella-associated protein 36, transcript variant X1
39S ribosomal protein L11, mitochondrial, transcript variant X1
39S ribosomal protein L11, mitochondrial, transcript variant X2
39S ribosomal protein L11, mitochondrial
cilia- and flagella-associated protein 36 isoform X1
cilia- and flagella-associated protein 36 isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 3
E3 ubiquitin-protein ligase synoviolin A, transcript variant X2
E3 ubiquitin-protein ligase synoviolin A, transcript variant X1
E3 ubiquitin-protein ligase synoviolin A isoform X2
E3 ubiquitin-protein ligase synoviolin A isoform X1
uncharacterized LOC124424139, transcript variant X3
uncharacterized LOC124424139, transcript variant X1
uncharacterized LOC124424139, transcript variant X2
uncharacterized protein LOC124424139 isoform X3
uncharacterized protein LOC124424139 isoform X2
uncharacterized protein LOC124424139 isoform X1
aldo-keto reductase family 1 member A1-like, transcript variant X2
aldo-keto reductase family 1 member A1-like, transcript variant X1
aldo-keto reductase family 1 member A1-like isoform X2
aldo-keto reductase family 1 member A1-like isoform X1
aldo-keto reductase family 1 member A1-like, transcript variant X3
aldo-keto reductase family 1 member A1-like isoform X3
DNA replication licensing factor Mcm5-like, transcript variant X4
DNA replication licensing factor Mcm5-like, transcript variant X1
DNA replication licensing factor Mcm5-like, transcript variant X2
DNA replication licensing factor Mcm5-like, transcript variant X3
DNA replication licensing factor Mcm5-like isoform X2
inactive Rho GTPase-activating protein 11B-like isoform X1
DNA replication licensing factor Mcm5-like
aldo-keto reductase family 1 member A1-like, transcript variant X4
replication stress response regulator SDE2
CLIP domain-containing serine protease 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X1
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial isoform X1
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X2
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial isoform X2
transient receptor potential channel pyrexia
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124424130, transcript variant X4
uncharacterized LOC124424130, transcript variant X10
uncharacterized LOC124424130, transcript variant X1
uncharacterized LOC124424130, transcript variant X5
uncharacterized LOC124424130, transcript variant X7
uncharacterized LOC124424130, transcript variant X2
uncharacterized LOC124424130, transcript variant X3
uncharacterized LOC124424130, transcript variant X11
uncharacterized LOC124424130, transcript variant X6
uncharacterized LOC124424130, transcript variant X8
uncharacterized LOC124424130, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RNA-binding protein Pasilla, transcript variant X5
RNA-binding protein Pasilla, transcript variant X1
RNA-binding protein Pasilla, transcript variant X2
RNA-binding protein Pasilla, transcript variant X3
RNA-binding protein Pasilla, transcript variant X4
molybdopterin synthase catalytic subunit, transcript variant X2
molybdopterin synthase catalytic subunit, transcript variant X4
molybdopterin synthase catalytic subunit, transcript variant X1
molybdopterin synthase catalytic subunit, transcript variant X3
molybdopterin synthase catalytic subunit isoform X1
molybdopterin synthase catalytic subunit isoform X2
uncharacterized LOC124424408, transcript variant X3
uncharacterized LOC124424408, transcript variant X1
uncharacterized LOC124424408, transcript variant X2
uncharacterized LOC124424408, transcript variant X4
uncharacterized protein LOC124424408 isoform X1
uncharacterized protein LOC124424408 isoform X2
uncharacterized protein LOC124424408 isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RNA 3'-terminal phosphate cyclase, transcript variant X2
RNA 3'-terminal phosphate cyclase, transcript variant X1
RNA 3'-terminal phosphate cyclase isoform X2
RNA 3'-terminal phosphate cyclase isoform X1
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X5
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X4
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X3
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X2
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X1
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase isoform X1
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase isoform X2
copper-transporting ATPase 1, transcript variant X1
copper-transporting ATPase 1, transcript variant X4
copper-transporting ATPase 1, transcript variant X2
copper-transporting ATPase 1, transcript variant X3
serine/threonine-protein kinase BRSK2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2 isoform X7
apoptosis regulatory protein Siva-like, transcript variant X2
apoptosis regulatory protein Siva-like, transcript variant X3
apoptosis regulatory protein Siva-like, transcript variant X4
apoptosis regulatory protein Siva-like, transcript variant X1
serine/threonine-protein kinase BRSK2, transcript variant X5
serine/threonine-protein kinase BRSK2, transcript variant X8
serine/threonine-protein kinase BRSK2, transcript variant X2
serine/threonine-protein kinase BRSK2, transcript variant X4
serine/threonine-protein kinase BRSK2, transcript variant X6
serine/threonine-protein kinase BRSK2, transcript variant X1
serine/threonine-protein kinase BRSK2, transcript variant X3
serine/threonine-protein kinase BRSK2 isoform X5
serine/threonine-protein kinase BRSK2 isoform X4
serine/threonine-protein kinase BRSK2 isoform X8
serine/threonine-protein kinase BRSK2 isoform X6
serine/threonine-protein kinase BRSK2 isoform X2
serine/threonine-protein kinase BRSK2 isoform X1
serine/threonine-protein kinase BRSK2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124424389, transcript variant X10
uncharacterized LOC124424389, transcript variant X11
uncharacterized LOC124424389, transcript variant X9
uncharacterized LOC124424389, transcript variant X8
uncharacterized LOC124424389, transcript variant X1
uncharacterized LOC124424389, transcript variant X7
uncharacterized LOC124424389, transcript variant X6
uncharacterized LOC124424389, transcript variant X5
uncharacterized LOC124424389, transcript variant X4
uncharacterized LOC124424389, transcript variant X3
uncharacterized LOC124424389, transcript variant X2
uncharacterized protein LOC124424389 isoform X5
uncharacterized protein LOC124424389 isoform X6
uncharacterized protein LOC124424389 isoform X4
uncharacterized protein LOC124424389 isoform X3
uncharacterized protein LOC124424389 isoform X1
uncharacterized protein LOC124424389 isoform X2
uncharacterized LOC124424389, transcript variant X12
uncharacterized protein LOC124424389 isoform X7
uncharacterized LOC124424389, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC124424389 isoform X8
synaptotagmin-5-like, transcript variant X1
synaptotagmin-5-like, transcript variant X2
synaptotagmin-5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ribosome biogenesis protein BRX1 homolog
probable rRNA-processing protein EBP2 homolog
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X6
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X13
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X10
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X14
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X12
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X11
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X15
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X16
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X5
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X17
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X7
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X8
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X18
cAMP-specific 3',5'-cyclic phosphodiesterase, transcript variant X19
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X6
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X9
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X10
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X5
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X11
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X7
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X8
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X12
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X13
uncharacterized LOC124424366, transcript variant X2
uncharacterized LOC124424366, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetra-peptide repeat homeobox protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
proteasome adapter and scaffold protein ECM29, transcript variant X1
proteasome adapter and scaffold protein ECM29 isoform X1
proteasome adapter and scaffold protein ECM29, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
proteasome adapter and scaffold protein ECM29, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proteasome adapter and scaffold protein ECM29 isoform X2
LMBR1 domain-containing protein 2 homolog
uncharacterized protein MAL13P1.304-like, transcript variant X1
uncharacterized protein MAL13P1.304-like, transcript variant X2
uncharacterized protein MAL13P1.304-like isoform X2
uncharacterized LOC124424032, transcript variant X1
uncharacterized LOC124424032, transcript variant X2
uncharacterized protein LOC124424032 isoform X1
uncharacterized protein LOC124424032 isoform X2
death-associated protein kinase 1-like, transcript variant X1
death-associated protein kinase 1-like, transcript variant X8
death-associated protein kinase 1-like, transcript variant X7
death-associated protein kinase 1-like, transcript variant X2
death-associated protein kinase 1-like, transcript variant X3
death-associated protein kinase 1-like, transcript variant X4
death-associated protein kinase 1-like, transcript variant X5
death-associated protein kinase 1-like, transcript variant X6
death-associated protein kinase 1-like isoform X1
death-associated protein kinase 1-like isoform X3
death-associated protein kinase 1-like isoform X2
tropomyosin-2-like, transcript variant X1
tropomyosin-2-like, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X12
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X13
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X12
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X11
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X10
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X11
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum resident protein 44, transcript variant X2
endoplasmic reticulum resident protein 44, transcript variant X1
endoplasmic reticulum resident protein 44 isoform X1
endoplasmic reticulum resident protein 44 isoform X2
neo-calmodulin-like, transcript variant X6
neo-calmodulin-like, transcript variant X4
neo-calmodulin-like, transcript variant X5
neo-calmodulin-like, transcript variant X2
neo-calmodulin-like, transcript variant X1
neo-calmodulin-like, transcript variant X3
neo-calmodulin-like, transcript variant X7
broad-complex core protein isoforms 1/2/3/4/5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X13
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X1
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X8
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X6
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X4
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X11
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X2
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X9
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X3
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X5
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X7
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X10
broad-complex core protein isoforms 1/2/3/4/5-like, transcript variant X12
broad-complex core protein isoforms 1/2/3/4/5-like isoform X2
broad-complex core protein isoforms 1/2/3/4/5-like isoform X1
uncharacterized LOC124424449, transcript variant X2
uncharacterized LOC124424449, transcript variant X1
uncharacterized LOC124424449, transcript variant X3
transmembrane protein 94, transcript variant X4
transmembrane protein 94, transcript variant X3
transmembrane protein 94, transcript variant X2
transmembrane protein 94, transcript variant X6
transmembrane protein 94, transcript variant X5
transmembrane protein 94, transcript variant X1
myb-like protein I, transcript variant X7
myb-like protein I, transcript variant X2
signal transducer and activator of transcription B-like isoform X3
myb-like protein I, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
myb-like protein I, transcript variant X3
myb-like protein I, transcript variant X6
myb-like protein I, transcript variant X1
myb-like protein I, transcript variant X5
signal transducer and activator of transcription B-like isoform X2
signal transducer and activator of transcription B-like isoform X1
myb-like protein I, transcript variant X9
myb-like protein I, transcript variant X8
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, transcript variant X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, transcript variant X5
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, transcript variant X6
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X5
uncharacterized LOC124424038, transcript variant X1
uncharacterized LOC124424038, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X3
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X2
vacuolar protein sorting-associated protein 37A
procollagen-lysine,2-oxoglutarate 5-dioxygenase, transcript variant X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase, transcript variant X3
procollagen-lysine,2-oxoglutarate 5-dioxygenase, transcript variant X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase isoform X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase isoform X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase isoform X3
immunoglobulin domain-containing protein oig-4-like, transcript variant X3
immunoglobulin domain-containing protein oig-4-like, transcript variant X1
immunoglobulin domain-containing protein oig-4-like isoform X1
immunoglobulin domain-containing protein oig-4-like, transcript variant X2
immunoglobulin domain-containing protein oig-4-like isoform X2
transcription initiation factor IIA subunit 1, transcript variant X1
transcription initiation factor IIA subunit 1, transcript variant X2
transcription initiation factor IIA subunit 1 isoform X1
transcription initiation factor IIA subunit 1 isoform X2
scavenger receptor class B member 1, transcript variant X4
scavenger receptor class B member 1, transcript variant X1
scavenger receptor class B member 1, transcript variant X2
scavenger receptor class B member 1, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X4
A disintegrin and metalloproteinase with thrombospondin motifs 9-like
uncharacterized LOC124424440, transcript variant X3
uncharacterized LOC124424440, transcript variant X1
uncharacterized LOC124424440, transcript variant X2
uncharacterized protein LOC124424440 isoform X2
uncharacterized protein LOC124424440 isoform X1
uncharacterized protein LOC124424440 isoform X3
uncharacterized LOC124424436, transcript variant X6
uncharacterized LOC124424436, transcript variant X5
uncharacterized LOC124424436, transcript variant X3
uncharacterized LOC124424436, transcript variant X1
uncharacterized LOC124424436, transcript variant X2
uncharacterized LOC124424436, transcript variant X4
peptidyl-prolyl cis-trans isomerase-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase-like
guanine nucleotide-binding protein subunit beta-2, transcript variant X2
guanine nucleotide-binding protein subunit beta-2, transcript variant X1
guanine nucleotide-binding protein subunit beta-2
JNK-interacting protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
JNK-interacting protein 3, transcript variant X6
JNK-interacting protein 3, transcript variant X3
JNK-interacting protein 3, transcript variant X2
JNK-interacting protein 3, transcript variant X1
JNK-interacting protein 3, transcript variant X4
JNK-interacting protein 3, transcript variant X5
JNK-interacting protein 3, transcript variant X8
transcription factor Sp9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor Sp9-like, transcript variant X1
transcription factor Sp9-like isoform X1
transcription factor Sp9-like isoform X2
transcription factor Sp9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transcription factor Sp9-like isoform X3
obg-like ATPase 1, transcript variant X1
obg-like ATPase 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124424324
SPARC-related modular calcium-binding protein 2, transcript variant X6
SPARC-related modular calcium-binding protein 2, transcript variant X1
SPARC-related modular calcium-binding protein 2, transcript variant X4
SPARC-related modular calcium-binding protein 2, transcript variant X5
SPARC-related modular calcium-binding protein 2, transcript variant X7
SPARC-related modular calcium-binding protein 2, transcript variant X2
SPARC-related modular calcium-binding protein 2, transcript variant X3
SPARC-related modular calcium-binding protein 2 isoform X1
SPARC-related modular calcium-binding protein 2 isoform X2
SPARC-related modular calcium-binding protein 2 isoform X3
SPARC-related modular calcium-binding protein 2 isoform X4
SPARC-related modular calcium-binding protein 2 isoform X5
cyclin-dependent kinase 9-like, transcript variant X1
cyclin-dependent kinase 9-like, transcript variant X2
cyclin-dependent kinase 9-like isoform X2
cyclin-dependent kinase 9-like isoform X1
deoxynucleoside kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
deoxynucleoside kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
deoxynucleoside kinase-like, transcript variant X3
deoxynucleoside kinase-like, transcript variant X4
uncharacterized LOC124424165, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124424165, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 608-like, transcript variant X12
zinc finger protein 608-like, transcript variant X4
zinc finger protein 608-like, transcript variant X1
zinc finger protein 608-like, transcript variant X7
zinc finger protein 608-like, transcript variant X2
zinc finger protein 608-like, transcript variant X3
zinc finger protein 608-like, transcript variant X8
zinc finger protein 608-like, transcript variant X5
zinc finger protein 608-like, transcript variant X14
zinc finger protein 608-like, transcript variant X13
zinc finger protein 608-like, transcript variant X11
zinc finger protein 608-like, transcript variant X15
zinc finger protein 608-like, transcript variant X6
zinc finger protein 608-like, transcript variant X9
zinc finger protein 608-like, transcript variant X10
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5
uncharacterized LOC124424230, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124424230, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124424230, transcript variant X1
uncharacterized LOC124424230, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124424230, transcript variant X2
uncharacterized protein LOC124424230 isoform X1
uncharacterized protein LOC124424230 isoform X2
uncharacterized protein LOC124424230 isoform X3
uncharacterized protein LOC124424230 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
kinesin-like protein KIF2A, transcript variant X7
kinesin-like protein KIF2A, transcript variant X8
kinesin-like protein KIF2A, transcript variant X1
kinesin-like protein KIF2A, transcript variant X2
kinesin-like protein KIF2A, transcript variant X3
kinesin-like protein KIF2A, transcript variant X4
kinesin-like protein KIF2A, transcript variant X5
kinesin-like protein KIF2A, transcript variant X6
uncharacterized protein LOC124424524 isoform X1
protein adenylyltransferase Fic, transcript variant X1
protein adenylyltransferase Fic, transcript variant X2
protein adenylyltransferase Fic isoform X2
protein adenylyltransferase Fic isoform X1
ADP-ribosylation factor-like protein 16, transcript variant X2
ADP-ribosylation factor-like protein 16, transcript variant X1
ADP-ribosylation factor-like protein 16 isoform X2
ADP-ribosylation factor-like protein 16 isoform X1
MATH and LRR domain-containing protein PFE0570w-like
E3 ubiquitin ligase Rnf157, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
E3 ubiquitin ligase Rnf157, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
E3 ubiquitin ligase Rnf157, transcript variant X2
60S ribosomal protein L10, transcript variant X1
60S ribosomal protein L10, transcript variant X2
mediator of RNA polymerase II transcription subunit 9, transcript variant X3
mediator of RNA polymerase II transcription subunit 9, transcript variant X2
mediator of RNA polymerase II transcription subunit 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 9 isoform X1
mediator of RNA polymerase II transcription subunit 9 isoform X2
GTP-binding protein 1, transcript variant X2
GTP-binding protein 1, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X2
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X1
probable cytosolic Fe-S cluster assembly factor AAEL012261 isoform X2
dynein axonemal light chain 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dynein axonemal light chain 4-like, transcript variant X1
regulator of microtubule dynamics protein 1-like, transcript variant X2
regulator of microtubule dynamics protein 1-like, transcript variant X1
regulator of microtubule dynamics protein 1-like, transcript variant X3
regulator of microtubule dynamics protein 1-like
lysocardiolipin acyltransferase 1-like, transcript variant X4
lysocardiolipin acyltransferase 1-like, transcript variant X1
lysocardiolipin acyltransferase 1-like, transcript variant X2
lysocardiolipin acyltransferase 1-like, transcript variant X3
lysocardiolipin acyltransferase 1-like isoform X2
lysocardiolipin acyltransferase 1-like isoform X1
coiled-coil domain-containing protein 134-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124424047, transcript variant X3
uncharacterized LOC124424047, transcript variant X2
uncharacterized protein LOC124424047 isoform X3
uncharacterized protein LOC124424047 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124424047, transcript variant X1
uncharacterized protein LOC124424047 isoform X1
NADH-cytochrome b5 reductase-like, transcript variant X1
NADH-cytochrome b5 reductase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
NADH-cytochrome b5 reductase-like isoform X1
NADH-cytochrome b5 reductase-like isoform X2
E3 ubiquitin-protein ligase FANCL, transcript variant X2
E3 ubiquitin-protein ligase FANCL, transcript variant X1
E3 ubiquitin-protein ligase FANCL isoform X2
E3 ubiquitin-protein ligase FANCL isoform X1
glucose-6-phosphate exchanger SLC37A2, transcript variant X2
glucose-6-phosphate exchanger SLC37A2, transcript variant X1
glucose-6-phosphate exchanger SLC37A2, transcript variant X3
glucose-6-phosphate exchanger SLC37A2 isoform X1
glucose-6-phosphate exchanger SLC37A2 isoform X2
gamma-secretase subunit pen-2, transcript variant X2
gamma-secretase subunit pen-2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cuticle protein 16.8-like, transcript variant X1
cuticle protein 16.8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
alpha-tocopherol transfer protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-tocopherol transfer protein-like, transcript variant X1
alpha-tocopherol transfer protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 31
solute carrier family 22 member 8-like, transcript variant X2
solute carrier family 22 member 8-like, transcript variant X1
solute carrier family 22 member 8-like isoform X2
solute carrier family 22 member 8-like isoform X1
structure-specific endonuclease subunit slx1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
structure-specific endonuclease subunit slx1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
structure-specific endonuclease subunit slx1 isoform X2
structure-specific endonuclease subunit slx1 isoform X1
fructose-bisphosphate aldolase-like, transcript variant X3
fructose-bisphosphate aldolase-like, transcript variant X2
fructose-bisphosphate aldolase-like, transcript variant X1
fructose-bisphosphate aldolase-like isoform X2
fructose-bisphosphate aldolase-like isoform X1
fructose-bisphosphate aldolase-like isoform X3
fructose-bisphosphate aldolase 5, cytosolic-like, transcript variant X2
fructose-bisphosphate aldolase 5, cytosolic-like isoform X2
fructose-bisphosphate aldolase 5, cytosolic-like, transcript variant X1
fructose-bisphosphate aldolase 5, cytosolic-like isoform X1
ADP-ribosylation factor-like protein 6-interacting protein 4, transcript variant X1
ADP-ribosylation factor-like protein 6-interacting protein 4, transcript variant X2
ADP-ribosylation factor-like protein 6-interacting protein 4, transcript variant X3
ADP-ribosylation factor-like protein 6-interacting protein 4 isoform X1
ADP-ribosylation factor-like protein 6-interacting protein 4 isoform X2
RING finger and transmembrane domain-containing protein 2-like, transcript variant X2
RING finger and transmembrane domain-containing protein 2-like, transcript variant X3
RING finger and transmembrane domain-containing protein 2-like, transcript variant X1
RING finger and transmembrane domain-containing protein 2-like isoform X3
RING finger and transmembrane domain-containing protein 2-like isoform X1
RING finger and transmembrane domain-containing protein 2-like isoform X2
RING finger and transmembrane domain-containing protein 2-like, transcript variant X4
RING finger and transmembrane domain-containing protein 2-like isoform X4
probable citrate synthase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ras-like protein family member 10B, transcript variant X2
ras-like protein family member 10B, transcript variant X1
ras-like protein family member 10B isoform X2
ras-like protein family member 10B isoform X1
odorant receptor coreceptor, transcript variant X2
odorant receptor coreceptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endoglucanase E-4-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 186 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endoglucanase E-4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 186 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endoglucanase E-4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 186 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endoglucanase E-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 186 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
endoglucanase E-4-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 186 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
endoglucanase E-4-like, transcript variant X7
endoglucanase E-4-like, transcript variant X6
endoglucanase E-4-like, transcript variant X4
endoglucanase E-4-like, transcript variant X1
glucose dehydrogenase [FAD, quinone], transcript variant X1
glucose dehydrogenase [FAD, quinone] isoform X1
glucose dehydrogenase [FAD, quinone], transcript variant X2
glucose dehydrogenase [FAD, quinone] isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 47-like, transcript variant X2
leucine-rich repeat-containing protein 47-like, transcript variant X1
leucine-rich repeat-containing protein 47-like
CDP-diacylglycerol--inositol 3-phosphatidyltransferase, transcript variant X2
CDP-diacylglycerol--inositol 3-phosphatidyltransferase, transcript variant X1
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
protein SCAF11-like, transcript variant X1
protein SCAF11-like, transcript variant X3
uncharacterized protein LOC124424477 isoform X3
protein SCAF11-like, transcript variant X2
uncharacterized protein LOC124424477 isoform X1
uncharacterized protein MAL13P1.304-like, transcript variant X4
uncharacterized protein MAL13P1.304-like, transcript variant X3
uncharacterized protein MAL13P1.304-like isoform X1
uncharacterized protein MAL13P1.304-like isoform X3
uncharacterized protein MAL13P1.304-like isoform X4
phosphatidylserine lipase ABHD16A, transcript variant X2
phosphatidylserine lipase ABHD16A, transcript variant X1
ran GTPase-activating protein 1-like, transcript variant X2
ran GTPase-activating protein 1-like, transcript variant X1
bromodomain-containing protein 4-like, transcript variant X1
bromodomain-containing protein 4-like, transcript variant X2
bromodomain-containing protein 4-like, transcript variant X3
bromodomain-containing protein 4-like isoform X3
methionine-R-sulfoxide reductase B1, transcript variant X3
methionine-R-sulfoxide reductase B1, transcript variant X5
methionine-R-sulfoxide reductase B1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
methionine-R-sulfoxide reductase B1, transcript variant X6
methionine-R-sulfoxide reductase B1, transcript variant X7
methionine-R-sulfoxide reductase B1, transcript variant X1
methionine-R-sulfoxide reductase B1, transcript variant X2
methionine-R-sulfoxide reductase B1 isoform X1
methionine-R-sulfoxide reductase B1 isoform X2
methionine-R-sulfoxide reductase B1 isoform X3
methionine-R-sulfoxide reductase B1 isoform X6
methionine-R-sulfoxide reductase B1 isoform X7
methionine-R-sulfoxide reductase B1 isoform X5
methionine-R-sulfoxide reductase B1 isoform X4
serine/threonine-protein kinase Pak, transcript variant X5
serine/threonine-protein kinase Pak, transcript variant X4
serine/threonine-protein kinase Pak, transcript variant X2
serine/threonine-protein kinase Pak, transcript variant X1
serine/threonine-protein kinase Pak, transcript variant X3
serine/threonine-protein kinase Pak isoform X3
serine/threonine-protein kinase Pak isoform X5
serine/threonine-protein kinase Pak isoform X4
serine/threonine-protein kinase Pak isoform X2
serine/threonine-protein kinase Pak isoform X1
beta carbonic anhydrase 1, transcript variant X1
beta carbonic anhydrase 1, transcript variant X2
beta carbonic anhydrase 1, transcript variant X4
beta carbonic anhydrase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124424178, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124424178, transcript variant X1
uncharacterized LOC124424178, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
proline-, glutamic acid- and leucine-rich protein 1-like
60S ribosomal protein L8, transcript variant X2
60S ribosomal protein L8, transcript variant X1
ATP-dependent RNA helicase bel, transcript variant X2
ATP-dependent RNA helicase bel, transcript variant X4
ATP-dependent RNA helicase bel, transcript variant X1
ATP-dependent RNA helicase bel, transcript variant X3
ATP-dependent RNA helicase bel isoform X2
ATP-dependent RNA helicase DDX3X isoform X1
dynein regulatory complex protein 9-like
5'-nucleotidase domain-containing protein 3, transcript variant X2
5'-nucleotidase domain-containing protein 3, transcript variant X3
5'-nucleotidase domain-containing protein 3, transcript variant X1
5'-nucleotidase domain-containing protein 3 isoform X2
5'-nucleotidase domain-containing protein 3 isoform X1
tyrosine-protein kinase Drl, transcript variant X2
tyrosine-protein kinase Drl, transcript variant X1
tyrosine-protein kinase Drl, transcript variant X3
transcription factor Ken, transcript variant X1
transcription factor Ken, transcript variant X2
transcription factor Ken, transcript variant X3
apolipoprotein D-like, transcript variant X3
apolipoprotein D-like, transcript variant X1
apolipoprotein D-like, transcript variant X2
tyrosine-protein kinase Dnt-like, transcript variant X2
tyrosine-protein kinase Dnt-like isoform X2
tyrosine-protein kinase Dnt-like, transcript variant X1
tyrosine-protein kinase Dnt-like isoform X1
tyrosine-protein kinase Dnt-like, transcript variant X3
tyrosine-protein kinase Dnt-like isoform X3
A-agglutinin anchorage subunit-like, transcript variant X2
A-agglutinin anchorage subunit-like, transcript variant X1
uncharacterized protein LOC124424213 isoform X2
A-agglutinin anchorage subunit-like isoform X1
uncharacterized LOC124424107, transcript variant X1
uncharacterized LOC124424107, transcript variant X2
uncharacterized protein LOC124424107 isoform X1
uncharacterized protein LOC124424107 isoform X2
uncharacterized LOC124424011, transcript variant X1
uncharacterized LOC124424011, transcript variant X2
uncharacterized protein LOC124424011 isoform X1
uncharacterized protein LOC124424011 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 30, transcript variant X2
mediator of RNA polymerase II transcription subunit 30, transcript variant X1
mediator of RNA polymerase II transcription subunit 30 isoform X1
mediator of RNA polymerase II transcription subunit 30 isoform X2
RNA-binding protein 24-B-like, transcript variant X2
RNA-binding protein 24-B-like, transcript variant X3
RNA-binding protein 24-B-like, transcript variant X1
solute carrier organic anion transporter family member 74D, transcript variant X1
solute carrier organic anion transporter family member 74D, transcript variant X3
solute carrier organic anion transporter family member 74D, transcript variant X2
solute carrier organic anion transporter family member 74D
solute carrier organic anion transporter family member 2A1-like, transcript variant X2
solute carrier organic anion transporter family member 2A1-like, transcript variant X1
solute carrier organic anion transporter family member 2A1-like
homeobox protein dve-1, transcript variant X1
homeobox protein dve-1, transcript variant X2
homeobox protein dve-1, transcript variant X3
homeobox protein dve-1, transcript variant X4
KAT8 regulatory NSL complex subunit 1, transcript variant X1
KAT8 regulatory NSL complex subunit 1, transcript variant X2
KAT8 regulatory NSL complex subunit 1 isoform X1
KAT8 regulatory NSL complex subunit 1 isoform X2
excitatory amino acid transporter 1-like, transcript variant X3
excitatory amino acid transporter 1-like, transcript variant X4
excitatory amino acid transporter 1-like, transcript variant X1
excitatory amino acid transporter 1-like, transcript variant X2
excitatory amino acid transporter 1-like
single-stranded DNA-binding protein 3, transcript variant X1
single-stranded DNA-binding protein 3, transcript variant X6
single-stranded DNA-binding protein 3, transcript variant X2
single-stranded DNA-binding protein 3, transcript variant X4
single-stranded DNA-binding protein 3, transcript variant X5
single-stranded DNA-binding protein 3, transcript variant X3
single-stranded DNA-binding protein 3 isoform X1
single-stranded DNA-binding protein 3 isoform X6
single-stranded DNA-binding protein 3 isoform X2
single-stranded DNA-binding protein 3 isoform X4
single-stranded DNA-binding protein 3 isoform X5
single-stranded DNA-binding protein 3 isoform X3
glycine receptor subunit alpha-3, transcript variant X3
glycine receptor subunit alpha-3, transcript variant X6
glycine receptor subunit alpha-3, transcript variant X4
glycine receptor subunit alpha-3 isoform X3
glycine receptor subunit alpha-3, transcript variant X1
glycine receptor subunit alpha-3, transcript variant X2
glycine receptor subunit alpha-3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycine receptor subunit alpha-3 isoform X1
glycine receptor subunit alpha-2 isoform X2
glycine receptor subunit alpha-3 isoform X4
glycine receptor subunit alpha-3 isoform X5
laminin subunit beta-1, transcript variant X2
laminin subunit beta-1, transcript variant X1
laminin subunit beta-1, transcript variant X4
laminin subunit beta-1, transcript variant X3
uncharacterized LOC124424415, transcript variant X3
uncharacterized LOC124424415, transcript variant X1
uncharacterized LOC124424415, transcript variant X2
uncharacterized protein LOC124424415 isoform X2
uncharacterized protein LOC124424415 isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X3
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like
putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase
protein abrupt-like, transcript variant X1
protein abrupt-like, transcript variant X2
protein abrupt-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine-rich adhesin for platelets, transcript variant X1
serine-rich adhesin for platelets, transcript variant X3
serine-rich adhesin for platelets, transcript variant X2
serine-rich adhesin for platelets isoform X3
serine-rich adhesin for platelets isoform X2
serine-rich adhesin for platelets isoform X1
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X8
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X15
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X5
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X6
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X7
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X9
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X18
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X19
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X17
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X20
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X13
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X14
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X21
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X10
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X12
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X11
phosphatidylinositol-binding clathrin assembly protein isoform X12
phosphatidylinositol-binding clathrin assembly protein isoform X5
phosphatidylinositol-binding clathrin assembly protein isoform X3
phosphatidylinositol-binding clathrin assembly protein isoform X8
phosphatidylinositol-binding clathrin assembly protein isoform X17
phosphatidylinositol-binding clathrin assembly protein isoform X7
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X15
phosphatidylinositol-binding clathrin assembly protein isoform X4
phosphatidylinositol-binding clathrin assembly protein isoform X16
phosphatidylinositol-binding clathrin assembly protein isoform X6
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X14
phosphatidylinositol-binding clathrin assembly protein isoform X2
phosphatidylinositol-binding clathrin assembly protein isoform X9
phosphatidylinositol-binding clathrin assembly protein isoform X1
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X11
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X18
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X10
phosphatidylinositol-binding clathrin assembly protein unc-11, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein isoform X13
KICSTOR complex protein kaptin-like, transcript variant X1
KICSTOR complex protein kaptin-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
KICSTOR complex protein kaptin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
KICSTOR complex protein kaptin-like, transcript variant X4
KICSTOR complex protein kaptin-like isoform X1
KICSTOR complex protein kaptin-like isoform X2
little elongation complex subunit 2-like
zinc finger protein 143-like, transcript variant X3
zinc finger protein 143-like, transcript variant X1
zinc finger protein 143-like, transcript variant X2
uncharacterized protein LOC124424486 isoform X1
uncharacterized protein LOC124424486 isoform X2
guanine nucleotide-binding protein subunit beta-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, transcript variant X2
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, transcript variant X3
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, transcript variant X4
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, transcript variant X1
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X2
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
oligoribonuclease, mitochondrial, transcript variant X2
oligoribonuclease, mitochondrial isoform X2
oligoribonuclease, mitochondrial, transcript variant X3
oligoribonuclease, mitochondrial, transcript variant X1
oligoribonuclease, mitochondrial isoform X3
uncharacterized LOC124424517, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124424517, transcript variant X1
uncharacterized LOC124424517, transcript variant X2
Kv channel-interacting protein 2-like, transcript variant X1
Kv channel-interacting protein 2-like, transcript variant X4
Kv channel-interacting protein 2-like, transcript variant X2
Kv channel-interacting protein 2-like, transcript variant X5
Kv channel-interacting protein 2-like, transcript variant X3
Kv channel-interacting protein 1-like isoform X1
Kv channel-interacting protein 2-like isoform X2
Kv channel-interacting protein 2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable 28S ribosomal protein S26, mitochondrial
mothers against decapentaplegic homolog 4, transcript variant X4
mothers against decapentaplegic homolog 4, transcript variant X2
mothers against decapentaplegic homolog 4, transcript variant X6
mothers against decapentaplegic homolog 4, transcript variant X8
mothers against decapentaplegic homolog 4, transcript variant X7
mothers against decapentaplegic homolog 4, transcript variant X5
mothers against decapentaplegic homolog 4, transcript variant X3
mothers against decapentaplegic homolog 4, transcript variant X1
mothers against decapentaplegic homolog 4 isoform X3
mothers against decapentaplegic homolog 4 isoform X5
mothers against decapentaplegic homolog 4 isoform X4
mothers against decapentaplegic homolog 4 isoform X2
mothers against decapentaplegic homolog 4 isoform X1
transmembrane emp24 domain-containing protein eca
protein stunted-like, transcript variant X1
protein stunted-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
putative lipoyltransferase 2, mitochondrial
ectopic P granules protein 5 homolog, transcript variant X2
ectopic P granules protein 5 homolog, transcript variant X1
ectopic P granules protein 5 homolog isoform X2
ectopic P granules protein 5 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X2
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog isoform X2
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog isoform X3
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog isoform X1
protein SDA1 homolog, transcript variant X1
protein SDA1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
AP-2 complex subunit mu, transcript variant X1
AP-2 complex subunit mu, transcript variant X2
calmodulin-binding transcription activator 2-like, transcript variant X1
calmodulin-binding transcription activator 2-like, transcript variant X2
calmodulin-binding transcription activator 2-like, transcript variant X3
calmodulin-binding transcription activator 2-like isoform X1
calmodulin-binding transcription activator 2-like isoform X3
calmodulin-binding transcription activator 2-like isoform X2
calmodulin-binding transcription activator 2-like, transcript variant X4
calmodulin-binding transcription activator 2-like isoform X4
RING finger protein nhl-1, transcript variant X5
RING finger protein nhl-1, transcript variant X1
RING finger protein nhl-1, transcript variant X2
RING finger protein nhl-1, transcript variant X3
RING finger protein nhl-1, transcript variant X4
RING finger protein nhl-1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
golgin subfamily A member 6-like protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
5-hydroxytryptamine receptor 2A, transcript variant X2
5-hydroxytryptamine receptor 2A, transcript variant X1
5-hydroxytryptamine receptor 2A, transcript variant X3
5-hydroxytryptamine receptor 2A isoform X1
5-hydroxytryptamine receptor 2A isoform X2
atypical protein kinase C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
atypical protein kinase C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
atypical protein kinase C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
atypical protein kinase C, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like
ubiquinone biosynthesis O-methyltransferase, mitochondrial-like, transcript variant X2
ubiquinone biosynthesis O-methyltransferase, mitochondrial-like, transcript variant X4
ubiquinone biosynthesis O-methyltransferase, mitochondrial-like, transcript variant X1
ubiquinone biosynthesis O-methyltransferase, mitochondrial-like, transcript variant X3
ubiquinone biosynthesis O-methyltransferase, mitochondrial-like
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SH3 domain-containing protein Dlish, transcript variant X2
SH3 domain-containing protein Dlish, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
general transcriptional corepressor CYC8, transcript variant X4
general transcriptional corepressor CYC8, transcript variant X2
general transcriptional corepressor CYC8, transcript variant X1
general transcriptional corepressor CYC8, transcript variant X3
general transcriptional corepressor CYC8
venom allergen 3-like, transcript variant X2
venom allergen 3-like, transcript variant X3
venom allergen 3-like, transcript variant X1
venom allergen 3-like, transcript variant X4
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X4
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X8
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X5
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X6
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X9
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X2
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X1
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X7
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X3
calcium-binding mitochondrial carrier protein Aralar1 isoform X4
calcium-binding mitochondrial carrier protein Aralar1 isoform X5
calcium-binding mitochondrial carrier protein Aralar1 isoform X3
calcium-binding mitochondrial carrier protein Aralar1 isoform X2
calcium-binding mitochondrial carrier protein Aralar1 isoform X1
calcium-binding mitochondrial carrier protein Aralar1 isoform X6
calcium-binding mitochondrial carrier protein Aralar1 isoform X7
protein transport protein Sec24C, transcript variant X2
protein transport protein Sec24C, transcript variant X1
heparan-alpha-glucosaminide N-acetyltransferase
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X1
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X2
putative mediator of RNA polymerase II transcription subunit 26 isoform X1
putative mediator of RNA polymerase II transcription subunit 26 isoform X2
uncharacterized LOC124424510, transcript variant X3
uncharacterized LOC124424510, transcript variant X1
uncharacterized LOC124424510, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124424510, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
forkhead box protein P1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
forkhead box protein P1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
forkhead box protein P1, transcript variant X13
forkhead box protein P1, transcript variant X12
forkhead box protein P1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
forkhead box protein P1, transcript variant X18
forkhead box protein P1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
forkhead box protein P1, transcript variant X10
forkhead box protein P1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
forkhead box protein P1, transcript variant X9
forkhead box protein P1, transcript variant X3
forkhead box protein P1, transcript variant X1
forkhead box protein P1, transcript variant X8
forkhead box protein P1, transcript variant X7
forkhead box protein P1, transcript variant X14
forkhead box protein P1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
forkhead box protein P1, transcript variant X16
forkhead box protein P1, transcript variant X15
histone deacetylase complex subunit SAP18
dual serine/threonine and tyrosine protein kinase-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase-like, transcript variant X5
dual serine/threonine and tyrosine protein kinase-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase-like, transcript variant X2
dual serine/threonine and tyrosine protein kinase-like, transcript variant X12
dual serine/threonine and tyrosine protein kinase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase-like, transcript variant X1
dual serine/threonine and tyrosine protein kinase-like isoform X1
dual serine/threonine and tyrosine protein kinase-like isoform X2
dual serine/threonine and tyrosine protein kinase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase-like, transcript variant X9
dual serine/threonine and tyrosine protein kinase-like, transcript variant X11
dual serine/threonine and tyrosine protein kinase-like, transcript variant X7
dual serine/threonine and tyrosine protein kinase-like isoform X3
dual serine/threonine and tyrosine protein kinase-like isoform X4
COMM domain-containing protein 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
COMM domain-containing protein 7-like, transcript variant X2
COMM domain-containing protein 7-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
COMM domain-containing protein 7-like, transcript variant X1
cell wall protein DAN4-like, transcript variant X2
cell wall protein DAN4-like, transcript variant X8
cell wall protein DAN4-like, transcript variant X9
cell wall protein DAN4-like, transcript variant X1
cell wall protein DAN4-like, transcript variant X4
cell wall protein DAN4-like, transcript variant X5
cell wall protein DAN4-like, transcript variant X10
uncharacterized protein LOC124424304 isoform X4
uncharacterized protein LOC124424304 isoform X1
cell wall protein DAN4-like, transcript variant X6
cell wall protein DAN4-like, transcript variant X7
cell wall protein DAN4-like, transcript variant X3
uncharacterized protein LOC124424304 isoform X2
uncharacterized protein LOC124424304 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras-related protein Rap1, transcript variant X2
ras-related protein Rap1, transcript variant X1
peroxisome biogenesis factor 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peroxisome biogenesis factor 10-like isoform X1
peroxisome biogenesis factor 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
peroxisome biogenesis factor 10-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
peroxisome biogenesis factor 10-like, transcript variant X6
peroxisome biogenesis factor 10-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
peroxisome biogenesis factor 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
peroxisome biogenesis factor 10-like isoform X2
myotubularin-related protein 14, transcript variant X5
myotubularin-related protein 14 isoform X2
myotubularin-related protein 14, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
myotubularin-related protein 14, transcript variant X3
myotubularin-related protein 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
myotubularin-related protein 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
myotubularin-related protein 14 isoform X1
myotubularin-related protein 14, transcript variant X6
myotubularin-related protein 14 isoform X3
ADP-ribose pyrophosphatase, mitochondrial
uncharacterized LOC124424268, transcript variant X2
uncharacterized LOC124424268, transcript variant X1
uncharacterized protein LOC124424268 isoform X2
uncharacterized protein LOC124424268 isoform X1
uncharacterized LOC124424374, transcript variant X11
uncharacterized protein LOC124424374 isoform X4
uncharacterized LOC124424374, transcript variant X13
uncharacterized protein LOC124424374 isoform X6
uncharacterized LOC124424374, transcript variant X10
uncharacterized protein LOC124424374 isoform X3
uncharacterized LOC124424374, transcript variant X1
uncharacterized LOC124424374, transcript variant X8
uncharacterized LOC124424374, transcript variant X7
uncharacterized LOC124424374, transcript variant X3
uncharacterized LOC124424374, transcript variant X4
uncharacterized LOC124424374, transcript variant X9
uncharacterized LOC124424374, transcript variant X5
uncharacterized LOC124424374, transcript variant X6
uncharacterized LOC124424374, transcript variant X15
uncharacterized protein LOC124424374 isoform X8
uncharacterized LOC124424374, transcript variant X2
uncharacterized protein LOC124424374 isoform X1
uncharacterized protein LOC124424374 isoform X2
uncharacterized LOC124424374, transcript variant X12
uncharacterized protein LOC124424374 isoform X5
uncharacterized LOC124424374, transcript variant X14
uncharacterized protein LOC124424374 isoform X7
transmembrane protein 70 homolog, mitochondrial
nuclear pore complex protein Nup98-Nup96, transcript variant X3
nuclear pore complex protein Nup98-Nup96, transcript variant X4
nuclear pore complex protein Nup98-Nup96, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nuclear pore complex protein Nup98-Nup96, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nuclear pore complex protein Nup98-Nup96 isoform X2
nuclear pore complex protein Nup98-Nup96 isoform X3
nuclear pore complex protein Nup98-Nup96 isoform X1
C2 domain-containing protein 5, transcript variant X1
C2 domain-containing protein 5, transcript variant X2
C2 domain-containing protein 5, transcript variant X3
C2 domain-containing protein 5 isoform X1
C2 domain-containing protein 5 isoform X2
C2 domain-containing protein 5, transcript variant X4
C2 domain-containing protein 5 isoform X3
SUMO-activating enzyme subunit 2, transcript variant X4
SUMO-activating enzyme subunit 2, transcript variant X2
SUMO-activating enzyme subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SUMO-activating enzyme subunit 2, transcript variant X1
SUMO-activating enzyme subunit 2, transcript variant X5
SUMO-activating enzyme subunit 2 isoform X1
SUMO-activating enzyme subunit 2 isoform X2
carbohydrate sulfotransferase 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
carbohydrate sulfotransferase 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
carbohydrate sulfotransferase 11-like isoform X2
carbohydrate sulfotransferase 11-like isoform X1
YTH domain-containing protein 1, transcript variant X4
YTH domain-containing protein 1, transcript variant X3
YTH domain-containing protein 1, transcript variant X2
YTH domain-containing protein 1, transcript variant X1
uncharacterized LOC124424055, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC124424055, transcript variant X5
uncharacterized LOC124424055, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124424055, transcript variant X7
uncharacterized LOC124424055, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC124424055, transcript variant X2
uncharacterized LOC124424055, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124424055 isoform X1
uncharacterized protein LOC124424055 isoform X3
uncharacterized protein LOC124424055 isoform X2
uncharacterized protein LOC124424055 isoform X5
uncharacterized protein LOC124424055 isoform X4
vascular endothelial growth factor A-A-like
pentatricopeptide repeat-containing protein 1, mitochondrial
protein virilizer, transcript variant X2
protein virilizer, transcript variant X3
protein virilizer, transcript variant X1
protein virilizer, transcript variant X5
protein virilizer, transcript variant X4
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase, transcript variant X2
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase, transcript variant X1
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase isoform X1
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase isoform X2
ras-related protein Rab-35, transcript variant X2
ras-related protein Rab-35, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X8
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X6
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X7
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X5
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform-like isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform-like isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform-like isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform-like isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform-like isoform X5
glutathione S-transferase-like, transcript variant X2
glutathione S-transferase-like, transcript variant X1
probable pterin-4-alpha-carbinolamine dehydratase, transcript variant X1
probable pterin-4-alpha-carbinolamine dehydratase, transcript variant X2
probable pterin-4-alpha-carbinolamine dehydratase isoform X1
probable pterin-4-alpha-carbinolamine dehydratase isoform X2
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
uncharacterized LOC124424471, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124424471, transcript variant X1
uncharacterized LOC124424471, transcript variant X2
biotin--protein ligase, transcript variant X1
biotin--protein ligase, transcript variant X3
biotin--protein ligase, transcript variant X2
inositol hexakisphosphate kinase 1, transcript variant X1
inositol hexakisphosphate kinase 1, transcript variant X2
inositol hexakisphosphate kinase 1, transcript variant X3
inositol hexakisphosphate kinase 1 isoform X1
inositol hexakisphosphate kinase 1 isoform X2
chromodomain-helicase-DNA-binding protein 7, transcript variant X4
chromodomain-helicase-DNA-binding protein 7, transcript variant X7
chromodomain-helicase-DNA-binding protein 7, transcript variant X3
chromodomain-helicase-DNA-binding protein 7, transcript variant X1
chromodomain-helicase-DNA-binding protein 7, transcript variant X6
chromodomain-helicase-DNA-binding protein 7, transcript variant X5
chromodomain-helicase-DNA-binding protein 7, transcript variant X2
chromodomain-helicase-DNA-binding protein 7 isoform X5
chromodomain-helicase-DNA-binding protein 7 isoform X4
chromodomain-helicase-DNA-binding protein 7 isoform X2
chromodomain-helicase-DNA-binding protein 7 isoform X3
chromodomain-helicase-DNA-binding protein 7 isoform X6
chromodomain-helicase-DNA-binding protein 7 isoform X1
huntingtin-interacting protein 1, transcript variant X2
huntingtin-interacting protein 1, transcript variant X5
huntingtin-interacting protein 1, transcript variant X3
huntingtin-interacting protein 1, transcript variant X1
huntingtin-interacting protein 1, transcript variant X4
huntingtin-interacting protein 1 isoform X2
huntingtin-interacting protein 1 isoform X1
huntingtin-interacting protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear pore complex protein Nup155, transcript variant X6
nuclear pore complex protein Nup155, transcript variant X5
nuclear pore complex protein Nup155, transcript variant X4
nuclear pore complex protein Nup155, transcript variant X2
nuclear pore complex protein Nup155, transcript variant X8
nuclear pore complex protein Nup155, transcript variant X7
nuclear pore complex protein Nup155, transcript variant X3
nuclear pore complex protein Nup155, transcript variant X1
nuclear pore complex protein Nup155 isoform X2
nuclear pore complex protein Nup155 isoform X1
eukaryotic translation initiation factor 2-alpha kinase
small G protein signaling modulator 3 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
small G protein signaling modulator 3 homolog, transcript variant X1
small G protein signaling modulator 3 homolog isoform X1
small G protein signaling modulator 3 homolog isoform X2
golgin subfamily A member 4-like, transcript variant X1
golgin subfamily A member 4-like, transcript variant X2
golgin subfamily A member 4-like, transcript variant X8
golgin subfamily A member 4-like, transcript variant X5
golgin subfamily A member 4-like, transcript variant X3
golgin subfamily A member 4-like, transcript variant X4
golgin subfamily A member 4-like, transcript variant X6
golgin subfamily A member 4-like, transcript variant X7
A-kinase anchor protein 9-like isoform X1
golgin subfamily A member 4-like isoform X7
A-kinase anchor protein 9-like isoform X4
A-kinase anchor protein 9-like isoform X2
A-kinase anchor protein 9-like isoform X3
golgin subfamily A member 4-like isoform X5
golgin subfamily A member 4-like isoform X6
uncharacterized LOC124424219, transcript variant X2
uncharacterized LOC124424219, transcript variant X3
uncharacterized LOC124424219, transcript variant X4
uncharacterized LOC124424219, transcript variant X1
patched domain-containing protein 3, transcript variant X1
patched domain-containing protein 3, transcript variant X3
patched domain-containing protein 3, transcript variant X4
patched domain-containing protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
patched domain-containing protein 3 isoform X1
patched domain-containing protein 3 isoform X3
patched domain-containing protein 3 isoform X4
patched domain-containing protein 4 isoform X5
patched domain-containing protein 3, transcript variant X2
patched domain-containing protein 3 isoform X2
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
period circadian protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
period circadian protein-like, transcript variant X2
period circadian protein-like, transcript variant X3
period circadian protein-like, transcript variant X4
period circadian protein-like, transcript variant X6
period circadian protein-like, transcript variant X5
period circadian protein-like, transcript variant X7
period circadian protein-like isoform X2
period circadian protein-like isoform X4
period circadian protein-like isoform X6
period circadian protein-like isoform X3
period circadian protein-like isoform X5
period circadian protein-like isoform X7
ecdysone receptor-like, transcript variant X1
ecdysone receptor-like, transcript variant X2
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
activated Cdc42 kinase Ack, transcript variant X1
activated Cdc42 kinase Ack, transcript variant X4
activated Cdc42 kinase Ack, transcript variant X3
activated Cdc42 kinase Ack, transcript variant X5
activated Cdc42 kinase Ack, transcript variant X2
peptidyl-prolyl cis-trans isomerase sig-7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124424454, transcript variant X1
uncharacterized LOC124424454, transcript variant X3
uncharacterized LOC124424454, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tRNA (uracil-5-)-methyltransferase homolog A, transcript variant X4
tRNA (uracil-5-)-methyltransferase homolog A, transcript variant X5
tRNA (uracil-5-)-methyltransferase homolog A, transcript variant X1
tRNA (uracil-5-)-methyltransferase homolog A, transcript variant X3
tRNA (uracil-5-)-methyltransferase homolog A, transcript variant X6
tRNA (uracil-5-)-methyltransferase homolog A, transcript variant X2
tRNA (uracil-5-)-methyltransferase homolog A
lon protease homolog, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
lon protease homolog, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
lon protease homolog, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lon protease homolog, mitochondrial isoform X1
lon protease homolog, mitochondrial isoform X2
transmembrane protein 8B, transcript variant X1
transmembrane protein 8B, transcript variant X3
transmembrane protein 8B, transcript variant X2
transmembrane protein 8B, transcript variant X5
transmembrane protein 8B, transcript variant X4
WAS/WASL-interacting protein family member 1-like
ATP-binding cassette sub-family F member 3, transcript variant X1
ATP-binding cassette sub-family F member 3, transcript variant X4
ATP-binding cassette sub-family F member 3, transcript variant X3
ATP-binding cassette sub-family F member 3, transcript variant X2
ATP-binding cassette sub-family F member 3 isoform X1
ATP-binding cassette sub-family F member 3 isoform X2
ATP-binding cassette sub-family F member 3 isoform X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X1
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X2
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X4
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X2
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X1
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X4
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X5
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X5
dnaJ homolog subfamily B member 6-like, transcript variant X1
dnaJ homolog subfamily B member 6-like, transcript variant X3
dnaJ homolog subfamily B member 6-like, transcript variant X2
dnaJ homolog subfamily B member 6-like isoform X1
dnaJ homolog subfamily B member 6-like isoform X2
3'-5' RNA helicase YTHDC2-like, transcript variant X1
3'-5' RNA helicase YTHDC2-like, transcript variant X2
3'-5' RNA helicase YTHDC2-like isoform X1
3'-5' RNA helicase YTHDC2-like isoform X2
von Willebrand factor A domain-containing protein 8, transcript variant X1
von Willebrand factor A domain-containing protein 8, transcript variant X2
von Willebrand factor A domain-containing protein 8 isoform X1
von Willebrand factor A domain-containing protein 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: modular serine protease-like
uncharacterized LOC124424193, transcript variant X2
uncharacterized LOC124424193, transcript variant X1
uncharacterized protein LOC124424193 isoform X2
uncharacterized protein LOC124424193 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
KH homology domain-containing protein 4-like isoform X7
KH homology domain-containing protein 4-like isoform X6
KH homology domain-containing protein 4-like isoform X9
KH homology domain-containing protein 4-like isoform X8
BTB/POZ domain-containing protein 1-like, transcript variant X2
BTB/POZ domain-containing protein 1-like, transcript variant X1
BTB/POZ domain-containing protein 1-like isoform X2
BTB/POZ domain-containing protein 1-like isoform X1
uncharacterized LOC124424495, transcript variant X1
uncharacterized LOC124424495, transcript variant X2
DNA polymerase delta subunit 2-like, transcript variant X2
DNA polymerase delta subunit 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA polymerase delta subunit 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable ribosome biogenesis protein RLP24
DNA polymerase delta subunit 2-like isoform X1
DNA polymerase delta subunit 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA polymerase delta subunit 2-like isoform X2
neither inactivation nor afterpotential protein G
zinc finger protein chinmo, transcript variant X4
zinc finger protein chinmo, transcript variant X6
zinc finger protein chinmo, transcript variant X1
zinc finger protein chinmo, transcript variant X7
zinc finger protein chinmo, transcript variant X3
zinc finger protein chinmo, transcript variant X2
zinc finger protein chinmo, transcript variant X5
zinc finger protein chinmo, transcript variant X8
zinc finger protein chinmo, transcript variant X9
cytochrome b-c1 complex subunit Rieske, mitochondrial
coiled-coil domain-containing protein 43
dual specificity tyrosine-phosphorylation-regulated kinase mbk-2-like, transcript variant X2
dual specificity tyrosine-phosphorylation-regulated kinase mbk-2-like, transcript variant X1
dual specificity tyrosine-phosphorylation-regulated kinase mbk-2-like isoform X2
probable serine/threonine-protein kinase dyrk2 isoform X1
uncharacterized LOC124424498, transcript variant X3
uncharacterized LOC124424498, transcript variant X1
uncharacterized LOC124424498, transcript variant X2
DNA repair endonuclease XPF, transcript variant X1
DNA repair endonuclease XPF, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124424125
chloride channel CLIC-like protein 1, transcript variant X2
chloride channel CLIC-like protein 1 isoform X2
chloride channel CLIC-like protein 1, transcript variant X1
chloride channel CLIC-like protein 1 isoform X1
uncharacterized LOC124424298, transcript variant X1
uncharacterized LOC124424298, transcript variant X2
uncharacterized protein LOC124424298 isoform X1
uncharacterized protein LOC124424298 isoform X2
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
uncharacterized LOC124424270, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124424270, transcript variant X1
uncharacterized LOC124424270, transcript variant X5
uncharacterized LOC124424270, transcript variant X7
uncharacterized LOC124424270, transcript variant X8
uncharacterized LOC124424270, transcript variant X6
uncharacterized LOC124424270, transcript variant X3
uncharacterized LOC124424270, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124424270, transcript variant X9
uncharacterized protein LOC124424270 isoform X2
uncharacterized protein LOC124424270 isoform X1
uncharacterized protein LOC124424270 isoform X3
uncharacterized protein LOC124424270 isoform X4
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X3
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit
metalloproteinase inhibitor 1, transcript variant X3
metalloproteinase inhibitor 1, transcript variant X4
metalloproteinase inhibitor 1, transcript variant X1
metalloproteinase inhibitor 1 isoform X1
metalloproteinase inhibitor 1, transcript variant X2
metalloproteinase inhibitor 1, transcript variant X5
metalloproteinase inhibitor 1 isoform X2
uncharacterized LOC124424272, transcript variant X2
uncharacterized LOC124424272, transcript variant X1
uncharacterized protein LOC124424272 isoform X1
uncharacterized protein LOC124424272 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
troponin C, isoallergen Bla g 6.0201-like
troponin C, isoallergen Bla g 6.0101-like